Voleon Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Voleon Capital Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.32M	Sell	8,531 -342	-4%	-$233K	0.1%	211
2026 Q1	$6.86M	Sell	8,873 -737	-8%	-$564K	0.15%	150
2025 Q4	$7.42M	Sell	9,610 -16,108	-63%	-$10.9M	0.16%	136
2025 Q3	$14.5M	Buy	25,718 +7,055	+38%	+$3.99M	0.35%	55
2025 Q2	$9.8M	Buy	18,663 +17,419	+1,400%	+$9.72M	0.54%	34
2025 Q1	$789K	Buy	1,244 +573	+85%	+$394K	0.06%	228
2024 Q4	$478K	Buy	+671	New	+$563K	0.04%	255
2021 Q1	–	Sell	-41,500	Closed	-$20M	–	29
2020 Q4	$20M	Hold	41,500	–	–	2.14%	20
2020 Q3	$23.2M	Hold	41,500	–	–	8.84%	5
2020 Q2	$25.9M	Buy	+41,500	New	+$23.6M	10.85%	3

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Voleon Capital Management's REGN Position: Q2 2026 in Review

Voleon Capital Management reduced its Regeneron Pharmaceuticals (REGN) stake by 3.9% in Q2 2026, selling an estimated $233K and leaving 8,531 shares worth $5.32M. The position accounts for 0.1% of the portfolio, ranked #211.

Voleon Capital Management first reported a position in REGN in Q2 2020 and has held it in 10 quarters since. The position peaked at $25.9M in Q2 2020. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Voleon Capital Management held 8,531 shares of Regeneron Pharmaceuticals worth $5.32M as of Q2 2026.
Voleon Capital Management sold 342 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $233K.
Regeneron Pharmaceuticals made up 0.1% of Voleon Capital Management's portfolio in Q2 2026, its #211 holding.
Voleon Capital Management first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 10 quarters since.
Voleon Capital Management's Regeneron Pharmaceuticals position peaked at $25.9M in Q2 2020.
1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.